[Form 4] COLGATE PALMOLIVE CO Insider Trading Activity

Rhea-AI Filing Summary

Colgate-Palmolive's Chairman, President & CEO received equity awards on 09/11/2025 consisting of 28,314 restricted stock units and a stock option for 196,047 shares with an exercise price of $84.06. The restricted stock units vest in three equal annual installments starting one year after grant, and the option vests in equal annual installments over three years beginning one year after the grant, with an expiration in 2033. Following the transaction the reporting person directly beneficially owns 347,464 shares, and holds additional indirect holdings of 53,560 shares via the issuer's 401(k) trustee, 52,000 shares via a spouse trust, and 335 shares via another trust. The awards were reported on a Form 4 reflecting standard compensation plan grants to an executive director.

Positive

• Alignment with shareholders: RSUs and options vesting over three years tie executive pay to long-term performance
• Significant existing ownership: Direct beneficial ownership of 347,464 shares plus indirect holdings indicates executive has material stake

Negative

• Potential dilution: Option for 196,047 shares could dilute shareholders if exercised
• Concentration risk: Substantial holdings mainly held by a single executive may concentrate voting power

Insights

Financial Analyst

TL;DR: Executive received routine equity compensation; modest dilution risk, aligns incentives long-term.

The grant package is a standard mix of restricted stock units and stock options designed to retain and incentivize the CEO. The RSUs convert to shares over three years and the option vests similarly, which promotes multi-year alignment with shareholder outcomes. The option exercise price of $84.06 establishes the threshold for future intrinsic value; until exercised these are contingent on stock performance. The direct beneficial ownership of 347,464 shares plus indirect holdings signals meaningful existing alignment. Impact on outstanding share count appears limited relative to total market cap and represents routine compensation rather than extraordinary dilution.

Corporate Governance Expert

TL;DR: Vesting schedules and mix of RSUs/options follow best practices for retention and performance linkage.

The awards vest in equal annual installments over three years, a common structure to encourage retention and long-term performance. Combination of RSUs and options balances guaranteed value (RSUs) with performance upside (options). Reporting shows direct and indirect holdings through a 401(k) trustee and spouse trust, reflecting customary ownership arrangements. This disclosure is consistent with Section 16 reporting requirements and provides transparency on executive compensation timing and resulting ownership stakes.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wallace Noel R.

(Last) (First) (Middle)

C/O COLGATE-PALMOLIVE COMPANY

300 PARK AVENUE

(Street)

NEW YORK NY 10022

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
COLGATE PALMOLIVE CO [ CL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chairman, President & CEO

3. Date of Earliest Transaction (Month/Day/Year)
09/11/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/11/2025		A(1)		28,314	A	$0.0000	347,464	D
Common Stock								53,560	I	By Issuer's 401(k) Plan Trustee
Common Stock								52,000	I	By Spouse Trust
Common Stock								335	I	By Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$84.06	09/11/2025		A(2)		196,047		(3)	09/11/2033	Common Stock	196,047	$0.0000	196,047	D

Explanation of Responses:

1. Restricted stock unit award granted under the issuer's incentive compensation plan. The restricted stock unit award vests in equal 1/3 installments on each of the first, second and third anniversary of the date of grant.

2. Stock option award granted under the issuer's incentive compensation plan.

3. Option becomes exercisable in equal annual installments over three years beginning on the first anniversary of the September 11, 2025 grant date.

	/s/ Kristine Hutchinson, Attorney-in-Fact	09/12/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What equity awards did Colgate-Palmolive (CL) report for its CEO on the Form 4?

The Form 4 reports 28,314 restricted stock units and a stock option covering 196,047 shares with an exercise price of $84.06 granted on 09/11/2025.

When do the restricted stock units and options vest?

The RSUs vest in three equal annual installments beginning one year after the grant; the stock option vests in equal annual installments over three years beginning one year after the 09/11/2025 grant.

How many shares does the reporting person beneficially own after the reported transactions?

Following the reported transactions the reporting person directly beneficially owns 347,464 shares and also holds indirect interests of 53,560 shares via the 401(k) trustee, 52,000 shares via a spouse trust, and 335 shares via another trust.

What is the expiration date for the reported stock option?

The reported stock option expires in 2033 and becomes exercisable in equal annual installments over three years starting one year after the grant.

Was the Form 4 filed by a single reporting person or multiple filers?

The Form 4 was filed by one reporting person.